{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:49:24Z","timestamp":1759564164504,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12185-023-03647-2","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T10:01:56Z","timestamp":1690624916000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-9113","authenticated-orcid":false,"given":"Shin-ichi","family":"Fuchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaaki","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Sunami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Nobata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuiku","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Naiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Shimazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"3647_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2169\/internalmedicine.9206-17","volume":"57","author":"C Shimazaki","year":"2018","unstructured":"Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekijma Y, et al. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med. 2018;57:181\u20137.","journal-title":"Intern Med"},{"key":"3647_CR2","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2008-02-138156","volume":"112","author":"AD Wechalekar","year":"2008","unstructured":"Wechalekar AD, Lachmann HJ, Goodman HJ, Badwell A, Hawkins PN, Gillmore JD. AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome. Blood. 2008;112:4009\u201316.","journal-title":"Blood"},{"key":"3647_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3816\/CLM.2009.n.021","volume":"9","author":"G Palladini","year":"2009","unstructured":"Palladini G, Russo P, Bosoni T, Sarais G, Lavatelli F, Foli A, et al. AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entity. Clin Lymphoma Myeloma. 2009;9:80\u20133.","journal-title":"Clin Lymphoma Myeloma"},{"key":"3647_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41375-019-0667-6","volume":"34","author":"S Sidana","year":"2020","unstructured":"Sidana S, Larson DP, Greipp PT, He R, McPhail ED, Dispenzieri A, et al. IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features. Leukemia. 2020;34:1373\u201382.","journal-title":"Leukemia"},{"key":"3647_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41375-018-0286-7","volume":"33","author":"S Zanwar","year":"2019","unstructured":"Zanwar S, Abeykoon JP, Ansell SM, Gertz MA, Dispenzieri A, Muchtar E, et al. Primary systemic amyloidosis in patients with Waldenstr\u00f6m macroglobulinemia. Leukemia. 2019;33:790\u20134.","journal-title":"Leukemia"},{"key":"3647_CR6","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1200\/JCO.2015.63.3123","volume":"34","author":"S Sachchithanantham","year":"2016","unstructured":"Sachchithanantham S, Roussel M, Palladini G, Klersy C, Mahmood S, Venner CP, et al. European Collaborative Study defining clinical profile outcomes and novel prognostic criteria in monoclonal immunoglobulin M-related light chain amyloidosis. J Clin Oncol. 2016;34:2037\u201345.","journal-title":"J Clin Oncol"},{"key":"3647_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand P, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol. 2005;79:319\u201328.","journal-title":"Am J Hematol"},{"key":"3647_CR8","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","volume":"30","author":"G Palladini","year":"2012","unstructured":"Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: Impact on survival outcomes. J Clin Oncol. 2012;30:4541\u20139.","journal-title":"J Clin Oncol"},{"key":"3647_CR9","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","volume":"124","author":"G Palladini","year":"2014","unstructured":"Palladini G, Hegenbart U, Milani P, Kimmich C, Foli A, Ho AD, et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. 2014;124:2325\u201332.","journal-title":"Blood"},{"key":"3647_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"3647_CR11","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/j.bbmt.2018.12.003","volume":"25","author":"MH Sidiqi","year":"2019","unstructured":"Sidiqi MH, Buadi FK, Dispenzieri A, Warsame R, Lacy MQ, Dingli D, et al. Autologous stem cell transplant for IgM associated AL amyloidosis. Biol Blood Marrow Transplant. 2019;25:e108\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3647_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3816\/CLML.2011.n.033","volume":"11","author":"G Palladini","year":"2011","unstructured":"Palladini G, Foli A, Russo P, Milani P, Obici L, Lavatelli F, et al. Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexamethasone. Clin Lymphoma Myeloma Leuk. 2011;11:143\u20135.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3647_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood-2018-04-846493","volume":"132","author":"R Manwani","year":"2018","unstructured":"Manwani R, Sachchithanantham S, Mahmood S, Foard D, Scharpley F, Rezk T, et al. Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine. Blood. 2018;132:761\u20134.","journal-title":"Blood"},{"key":"3647_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1182\/blood-2017-09-806463","volume":"131","author":"T Pika","year":"2018","unstructured":"Pika T, Hegenbart U, Flodrova P, Maier B, Kimmich C, Sch\u00f6nland SO. First report of ibrutinib in IgM-related amyloidosis: Few responses, poor tolerability, and short survival. Blood. 2018;131:368\u201371.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03647-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03647-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03647-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:19:18Z","timestamp":1695730758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03647-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3647"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03647-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"10 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. F. received honoraria from Takeda, Sanofi, Janssen, Ono, Bristol-Myers Squibb. T. I. received honoraria from Ono, Takeda, Janssen, Sanofi, and Bristol-Myers Squibb, and received research funding from Takeda, Janssen, Pfizer, Bristol-Myers Squibb, and Sanofi. C. N. received honoraria from Janssen, Bristol-Myers Squibb, Novartis, Fujimoto, and Takeda. K. S. received honoraria from Ono, Bristol-Myers Squibb, Takeda, and Sanofi, and received research funding from Ono, Celgene, Abbvie, Takeda, Sanofi, Bristol-Myers Squibb, GlaxoSmithKlein, Chugai, Otsuka, and Janssen. S. I. received honoraria from Janssen, Bristol-Myers Squibb, Ono, Takeda, and Sanofi, and received research funding from Sanofi, Chugai, Ono, Takeda, Janssen, Bristol-Myers Squibb, Abbvie, Novartis, Amgen, Daiichi Sankyo, Otsuka, Celgene, Alexion and GlaxoSmithKlein. C. S. received honoraria from Sanofi, Janssen, Bristol-Myers Squibb.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}